Research Topics
| O MickeSummaryCountry: Germany Publications
| Collaborators
|
Detail Information
Publications
Selenium in the treatment of radiation-associated secondary lymphedemaOliver Micke
Department of Radiotherapy, Munster University Hospital, Munster, Germany
Int J Radiat Oncol Biol Phys 56:40-9. 2003..The aim of this explorative study was to evaluate the impact of selenium in the treatment of lymphedema after radiotherapy...- Radiotherapy in painful heel spurs (plantar fasciitis)--results of a national patterns of care studyOliver Micke
Department of Radiotherapy, Munster University Hospital, Munster, Germany
Int J Radiat Oncol Biol Phys 58:828-43. 2004..After a general patterns of care study, the German Cooperative Group on Radiotherapy for Benign Diseases conducted a multicenter cohort study to analyze radiotherapy (RT) in painful heel spur syndrome (HSS)... - [Plantar fasciitis and radiotherapy. Clinical and radiobiological treatment results]O Micke
Klinik und Poliklinik für Strahlentherapie Radioonkologie, Universitatsklinikum, Munster
Orthopade 34:579-91. 2005..5 and 4.0 Gy. These results may provide a possible explanation for a local anti-inflammatory effect of low-dose RT. RT may be an excellent alternative for patients with contraindications to long-term treatment with steroids or NSAID... 
Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility studyF J Prott
Department of Radiotherapy, , Medical School, Germany
Br J Cancer 75:597-601. 1997..The therapy could be applied in a short period of time, approximately half the time used in conventional therapy schemes...- Alpha-fetoprotein-positive carcinoma of the pancreas: a case reportS B Mueller
Department of Radiotherapy, , Germany
Anticancer Res 25:1671-4. 2005..Our patient is the youngest reported in the literature to date. When present, AFP expression is useful for diagnosis and as a marker for monitoring therapeutic response and recurrence of the disease... - The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancerO Micke
Department of Radiotherapy and Radiation Oncology, University of Munster, Munster, Germany
Anticancer Res 20:5113-5. 2000..The leading time ranged between one and 16 months (median: 3.1 months). In conclusion, SCC is a useful tumor marker in the follow-up of patients with squamous cell carcinoma of the uterine cervix... - Fractionated perioperative high dose rate brachytherapy using a tissue equivalent bendy applicatorS Könemann
Department of Radiotherapy, University Hospital, Munster, Germany
Br J Radiol 75:453-9. 2002.... - Selenium in the treatment of head and neck lymphedemaF Bruns
Department of Radiotherapy, Medical School Hannover, Hannover, Germany
Med Princ Pract 13:185-90. 2004..No episode of erysipelas was observed in all study patients. CONCLUSION: Our results suggest a short positive effect of sodium selenite on secondary head and neck lymphedema caused by radiotherapy alone or in combination with surgery... - Predictive value of carbohydrate antigen 19-9 in pancreatic cancer treated with radiochemotherapyOliver Micke
Department of Radiotherapy, Munster University Hospital, Munster, Germany
Int J Radiat Oncol Biol Phys 57:90-7. 2003..To determine the predictive value of carbohydrate antigen (CA) 19-9 in pancreatic cancer treated with radiochemotherapy... - Hemoglobin as an independent prognostic factor in the radiotherapy of head and neck tumorsUlrich Schäfer
Department of Radiotherapy, University Hospital Munster, Germany
Strahlenther Onkol 179:527-34. 2003..The purpose of this study was to analyze the prognostic value of baseline hemoglobin levels before radiotherapy in patients with head and neck tumors... - [Long-term results of postoperative radiotherapy for stage I endometrial carcinoma]Oliver Micke
Klinik und Poliklinik für Strahlentherapie Radioonkologie Universitätsklinikum Münster, Munster
Strahlenther Onkol 179:729-36. 2003..The impact of an additional external beam irradiation of the pelvis considering different prognostic criteria is still unclear... - Low-dose radiotherapy for painful heel spur. Retrospective study of 117 patientsRalph Mücke
Department of Radiotherapy, Radiation Oncology and Nuclear Medicine, Weiden Hospital, Weiden, Germany
Strahlenther Onkol 179:774-8. 2003..Retrospective analysis of 117 patients treated between 1996 and 2000 with low-dose radiotherapy (RT) for painful heel spurs... - Radiation therapy for nonmalignant diseases in Germany. Current concepts and future perspectivesM Heinrich Seegenschmiedt
Department of Radiation Oncology and Radiation Therapy, Alfried Krupp Hospital, Essen, Germany
Strahlenther Onkol 180:718-30. 2004..This development is reflected in a national patterns-of-care study (PCS) conducted during the years 2001-2002... - [Legal questions in radio-oncology. Demands on patient information and documentation of the therapy with examples of current legal cases concerning specialization in radiotherapy/radio-oncology]Stefan Hesselmann
Klinik und Poliklinik für Strahlentherapie Radioonkologie, Universitatsklinikum Munster, Munster, Germany
Strahlenther Onkol 180:256-62. 2004..As a rule-as a way out of difficulties-these claims for compensation are based on the accusation of mistaken or incomplete information, because if one cannot prove any wrong treatment, faulty information can (nearly) always be proven... - Radiation therapy for aggressive fibromatosis (desmoid tumors): results of a national Patterns of Care StudyOliver Micke
Department of Radiotherapy, Munster University Hospital, Albert Schweitzer Strasse 33, 48129 Munster, Germany
Int J Radiat Oncol Biol Phys 61:882-91. 2005..After a general Patterns of Care Study (PCS) the German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD) initiated a multicenter cohort study to analyze the radiation therapy practice for aggressive fibromatosis... - Surgery and radiotherapy of one rare case with neoplasm derived from fibroblastic reticulum cells of a cervical lymph nodeRalph Mücke
Department of Radiotherapy, Klinikum Weiden, Germany
Acta Oncol 43:766-8. 2004 - Treatment of bone metastases and local recurrence from renal cell carcinoma with immunochemotherapy and radiationOlaf Anselm Brinkmann
Department of Urology, University Clinic of Muenster, Albert Schweitzer Strasse 33, 48149 Munster, Germany
World J Urol 23:185-90. 2005.... - Randomized multicenter trial on the effect of radiotherapy for plantar Fasciitis (painful heel spur) using very low doses--a study protocolMarcus Niewald
Department of Radiooncology, Saarland University Hospital, Homburg, Germany
Radiat Oncol 3:27. 2008..The trial is supported by a HOMFOR grant (Saarland University Research Grant). TRIAL REGISTRATION: Current controlled trials ISRCTN94220918... - Consensus guidelines for radiation therapy of benign diseases: a multicenter approach in GermanyOliver Micke
Klinik und Poliklinik für Strahlentherapie Radioonkologie, Westfalische Wilhelms Universitat, Munster, Germany
Int J Radiat Oncol Biol Phys 52:496-513. 2002.... - [Radiotherapy within the scope of allogeneic kidney transplantation: an indication for local irradiation?]Oliver Micke
Klinik und Poliklinik für Strahlentherapie Radioonkologie, Universitatsklinikum Munster
Strahlenther Onkol 178:280-5. 2002..Despite major advantages in maintenance immunosuppression and management of acute allograft rejection a minority of patients remains with drug resistant transplant rejection. This subgroup of patients may benefit from LGI... - Microscopic residual disease is a risk factor in the primary treatment of breast cancerAndreas Schuck
Department of Radiotherapy of the University of Muenster, Germany
Strahlenther Onkol 178:307-13. 2002..In a retrospective analysis, our mono-institutional results of postoperative irradiation have been evaluated... - Functional evaluation of the human pancreas before and in the early period after hyperfractionated accelerated radiochemotherapyEckehard Horst
Department of Radiation Oncology, , Germany
Front Radiat Ther Oncol 37:17-25. 2002 - Radiotherapy for Graves' orbitopathy: results of a national surveyReinhard Heyd
Radiation Clinic, Offenbach Hospital, Offenbach, Germany
Strahlenther Onkol 179:372-6. 2003..We recommend to review the patterns of care for RT of other entities of benign diseases and to implement a quality assurance program both on national and international levels... - Palliative treatment of Erdheim-Chester disease with radiotherapy: a Rare Cancer Network studyRobert C Miller
Department of Radiation Oncology, Mayo Clinic, Rochester, MN 55905, USA
Radiother Oncol 80:323-6. 2006..Patients received EBRT for bone pain, brain infiltration, or retro-orbital involvement. EBRT typically provided short-term palliation, with later recurrence of symptoms in most cases... - Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?Hans Theodor Eich
Department of Radiation Oncology, University of Cologne, Cologne, Germany
Strahlenther Onkol 181:378-84. 2005..To investigate the influence of radio- and chemotherapy, the treatment and course of the disease in children and adolescents with ENB were analyzed retrospectively... - A long-term follow-up study after retro-orbital irradiation for Graves' ophthalmopathyUlrich Schaefer
Department of Radiotherapy and Radiooncology, University Hospital, Westfaelische Wilhelms University, Muenster, Germany
Int J Radiat Oncol Biol Phys 52:192-7. 2002.... - Radiotherapy in oncological emergencies--final results of a patterns of care study in Germany, Austria and SwitzerlandElmar Christian
Department of Internal Medicine, Paracelsus Hospital, Glückstadt, Germany
Acta Oncol 47:81-9. 2008..This study represents the largest database in literature on emergency RT. RT was shown to be fast, time sparing and a very effective treatment option for special oncological emergencies... - No predictive value of beta-hCG in patients with stage I seminoma--results of a long-term follow-up study after adjuvant radiotherapyFrank Bruns
Department of Radiotherapy, Hannover Medical School, Hannover, Germany
Anticancer Res 25:1543-6. 2005.... - PSA course after definitive high-dose radiotherapy of localized prostate cancerPatrick Schüller
Klinik und Poliklinik für Strahlentherapie Radioonkologie, Universitatsklinikum Munster, Germany
Anticancer Res 25:1555-7. 2005..The aim of this analysis was to investigate whether PSA also declines to near zero values after combined tele-brachytherapy... - The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapyOliver Micke
Department of Radiotherapy, Munster University Hospital, Munster, Germany
Anticancer Res 25:1663-6. 2005..In this retrospective analysis, the value of SCC correlated with prognosis in patients with carcinoma of the cervix treated with (chemo-)radiotherapy... - Influence of amifostine on late radiation-toxicity in head and neck cancer--a follow-up studyJens Büntzel
Department of Otolaryngology, Head and Neck Surgery, Sudharzkrankenhaus Nordhausen, Nordhausen, Germany
Anticancer Res 27:1953-6. 2007..The late toxicities due to multimodal therapy of advanced head and neck cancers were analysed. The impact of cytoprotection with amifostine is the specific objective of this report... - [Radiotherapy of Graves' ophthalmopathy--state of the art and review of the literature]Hans Theodor Eich
Klinik und Poliklinik für Strahlentherapie, Klinikum der Universität zu Köln, Joseph Stelzmann Str 9, 50924 Köln, Germany
Rontgenpraxis 56:137-44. 2007..This article describes the sequences, dosages and fractionation schemes as well as the risks and side effects of the radiotherapy... - 12 years' experience with intraoperative radiotherapy (IORT) of malignant gliomasPatrick Schueller
Department of Radiotherapy and Radiation Oncology, University Hospital, Muenster, Germany
Strahlenther Onkol 181:500-6. 2005..Even after surgery and radiotherapy, malignant gliomas still have a poor prognosis. The authors report on their experience with IORT in 71 patients... - Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III studyJens Buentzel
Department of Otolaryngology, Head and Neck Surgery, Suedharzkrankenhaus Nodhausen, Nordhausen, Germany
Int J Radiat Oncol Biol Phys 64:684-91. 2006..This randomized, double-blinded, placebo-controlled, phase III study evaluated the efficacy and safety of i.v. amifostine during radiochemotherapy for head-and-neck cancer... - 9 years tumor free survival after resection, intraoperative radiotherapy (IORT) and whole brain radiotherapy of a solitary brain metastasis of non-small cell lung cancerPatrick Schueller
Acta Oncol 45:224-5. 2006 - Irradiation causes biphasic neutrophilic granulocyte phagocytic functionOliver Micke
Department of Radiotherapy, Munster University Hospital, Munster, Germany
Strahlenther Onkol 181:313-8; discussion 319. 2005..The current study examines the influence of low radiation doses on neutrophilic granulocyte function, which could be helpful in finding the optimal dose for either stimulation or suppression of anti-inflammatory activity... - Accelerated radiochemotherapy in pancreatic cancer is not necessarily related to a pathologic pancreatic function decline in the early periodEckehard Horst
Department of Radiation Oncology, University of Munster, Munster, Germany
Int J Radiat Oncol Biol Phys 52:304-9. 2002..To evaluate the functional effects of ionizing radiation in patients with unresectable pancreatic cancer in the early period after accelerated radiochemotherapy (ART)... - Adjuvant radiotherapy in locally confined prostate cancerUlrich Schäfer
Department of Radiotherapy, University of Muenster, Albert Schweitzer Strasse 33, D 48129 Munster, Germany
Anticancer Res 23:983-5. 2003..The role of adjuvant radiotherapy (RT) following radical prostatectomy (RP) remains controversial. The aim of this study was to evaluate the benefit of adjuvant radiotherapy through PSA-level measurements... - The clinical value of squamous cell carcinoma antigen in patients irradiated for locally advanced cancer of the head and neckOliver Micke
Klinik und Poliklinik für Strahlentherapie Radioonkologie, Universitatsklinikum Munster, Albert Schweitzer Str 33, 48129 Munster, Germany
Anticancer Res 23:907-11. 2003..This study examines the value of squamous cell cancer (SCC) antigen in patients irradiated for locally advanced cancer of the head and neck... - CA 19-9 in the therapy monitoring and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapyOliver Micke
Klinik und Poliklinik für Strahlentherapie Radioonkologie, Universitatsklinikum Munster, 48129 Munster, Germany
Anticancer Res 23:835-40. 2003..The aim of this study was to determine the value of CA 19-9 in therapy monitoring and follow-up of locally advanced pancreatic cancer treated by radiochemotherapy... - Complementary and alternative medicine in radiotherapy patients--more harm than expected? In regard to D'Amico et al.: self-administration of untested medical therapy for treatment of prostate cancer can lead to clinically significant adverse events. IJROOliver Micke
Int J Radiat Oncol Biol Phys 57:1197-8; author reply 1198. 2003 - Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastomaHans Theodor Eich
Department of Radiotherapy, University of Cologne, Germany
Strahlenther Onkol 179:233-40. 2003..To evaluate the efficacy of multimodality therapy in patients with esthesioneuroblastoma (ENB)... - Influence of fractionated irradiation on neutrophilic granulocyte functionAlfred Haidenberger
Department of Radiotherapy, Leopold Franzens University Innsbruck, Austria
Strahlenther Onkol 179:45-9. 2003..In clinical practice, by contrast, fractionated irradiation is applied. Therefore, the aim of the current study was to verify the influence of fractionated radiation therapy on granulocyte function... - The effect of sequential radiochemotherapy in preirradiated malignant gliomas in a phase II studyUlrich Schäfer
Department of Radiotherapy, University of Muenster, Muenster, Germany
J Neurooncol 67:233-9. 2004..Palliative and survival benefits are modest. Evaluation of late toxicities needs further investigations... - Long-term alterations of oral mucosa in radiotherapy patientsFranz Josef Prott
Department of Radiotherapy, University of Munster, Munster, Germany
Int J Radiat Oncol Biol Phys 54:203-10. 2002..The aim of this investigation was to describe the alterations in oral mucosa after radiotherapy... - Current status of selenium and other treatments for secondary lymphedemaFrank Bruns
Department of Radiotherapy, Hannover Medical School, Hannover, Germany
J Support Oncol 1:121-30. 2003..The very low toxicity profile of selenium and its cost effectiveness are further arguments for its use in lymphedema treatment... - Selenium influences the radiation sensitivity of C6 rat glioma cellsPatrick Schueller
Department of Radiotherapy and Radiation Oncology, University Hospital of Muenster, Germany
Anticancer Res 24:2913-7. 2004..A radioprotective effect of low selenium doses on normal tissue and a possible radiosensitization of tumor cells at higher concentrations have been previously suggested. However, systematic experimental and clinical data are scarce... - Intraoperative radiation therapy (IORT) in primary locally advanced and recurrent carcinoma of the rectum at a "non-dedicated" facilityStefan Hesselmann
Department of Radiotherapy and Radiooncology, University Hospital Muenster, D 48129 Muenster, Germany
Anticancer Res 23:1875-81. 2003..Our aim was to perform IORT at a "non-dedicated" facility to improve the local tumour control rate without increasing the complication rate... - Systemic mast cell disease (SMCD) and bone pain. A case treated with radiotherapyStefan Hesselmann
Department of Radiotherapy and Radiooncology, University Hospital Muenster, Germany
Strahlenther Onkol 178:275-9. 2002..The cause of SMCD is unknown. Bony pain, caused by mast cell infiltration of the marrow cavity, is present in up to 28% of cases and is frequently chronic and difficult to palliate with medical therapy... - Carcinoembryonic antigen (CEA)--a useful marker for the detection of recurrent disease in endometrial carcinoma patientsFrank Bruns
Department of Radiation Oncology, University of Muenster, Albert-Schweitzer-Strasse 33, D-48129 Muenster, Germany
Anticancer Res 23:1103-6. 2003..However, in none of these reported cases had the increased CEA level influenced the therapeutic decision. Therefore, the routine measurement of CEA in asymptomatic follow-up patients is not recommended... - Results and follow-up of locally advanced cancer of the exocrine pancreas treated with radiochemotherapyOliver Micke
Department of Radiotherapy, Munster University Hospital, Munster, Germany
Anticancer Res 25:1523-30. 2005..In locally advanced carcinoma of the exocrine pancreas combined radiochemotherapy has been established as a standard treatment...